The adverse events of ibogaine in humans: an updated systematic review of the literature (2015

The adverse events of ibogaine in humans: an updated systematic review of the literature (2015–2020)

Published:2021-08-18 Issue: Volume: Page:
ISSN:0033-3158
Container-title:Psychopharmacology
language:en
Short-container-title:Psychopharmacology

Author:

Ona Genís,Rocha Juliana Mendes,Bouso José Carlos,Hallak Jaime E. C.,Borràs Tre,Colomina Maria Teresa,dos Santos Rafael G.

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s00213-021-05964-y.pdf

Reference55 articles.

1. Aceto M, Bowman E, Harris L (1990) Dependence studies of new compounds in the rhesus monkey, rat, and mouse. Natl Instit Drug Addict Res Monogr 95:578–631

2. Alper KR (2001) Ibogaine: a review. Alkaloids Chem Biol 56:1–38. https://doi.org/10.1016/s0099-9598(01)56005-8

3. Alper KR, Lotsof HS. (2007) Psychedelic medicine: new evidence for hallucinogenic substances as treatments. Westport (CT): Praeger Perspectives. The use of ibogaine in the treatment of addictions; p. 43–66.

4. Alper KR, Lotsof HS, Kaplan CD (2008) The ibogaine medical subculture. J Ethnopharmacol 115:9–24. https://doi.org/10.1016/j.jep.2007.08.034

5. Alper KR, Stajić M, Gill JR (2012) Fatalities temporally associated with the ingestion of ibogaine. J Forensic Sci 57(2):398–412. https://doi.org/10.1111/j.1556-4029.2011.02008.x

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The pharmacokinetics and pharmacodynamics of ibogaine in opioid use disorder patients;Journal of Psychopharmacology;2024-03-22

2. Psychedelic Therapy: A Primer for Primary Care Clinicians—Ibogaine;American Journal of Therapeutics;2024-03

3. Magnesium–ibogaine therapy in veterans with traumatic brain injuries;Nature Medicine;2024-01-05

4. 5-MeO-DMT: An atypical psychedelic with unique pharmacology, phenomenology & risk?;Psychopharmacology;2023-12-11

5. Guidelines for Establishing Safety in Ayahuasca and Ibogaine Administration in Clinical Settings;Psychoactives;2023-12-11